From Growth factor shows promise for Phelan-McDermid syndrome...

From Growth factor shows promise for Phelan-McDermid syndrome

"Last week, a separate set of researchers announced that the drug appears to be safe and effective in a trial of 53 adolescents and adults with Rett syndrome."

The inference is that IGF-1 was the drug being used instead of NNZ-2566. Only later on do you learn that:

"The Rett trial uses a modified form of IGF-1 that includes only the first three amino acids, but which may induce production of the full-length form in the brain"


I have noticed in a number of articles IGF-1 was being hyped and NNZ-2566 downplayed or not mentioned (as in the above announcement). To me IGF-1 is a competitor.